Evidence map›Paper›PMID 26618145›Full record

ArticleThe journal of prevention of Alzheimer's disease2015

Assessment of Age-Related Differences in Functional Capacity Using the Virtual Reality Functional Capacity Assessment Tool (VRFCAT).

A S Atkins, I Stroescu, N B Spagnola, V G Davis, T D Patterson, M Narasimhan, P D Harvey, R S E Keefe

Open access · greenAbstract read
In one paragraph

Article in The journal of prevention of Alzheimer's disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. The Computerized Functional Skills Assessment and Training Program: Sensitivity to Global Cognitive Impairment, Correlations With Cognitive Abilities, and Factor Structure.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

A S AtkinsNeuroCog Trials, Inc.
I StroescuNeuroCog Trials, Inc.
N B SpagnolaNeuroCog Trials, Inc.
V G DavisNeuroCog Trials, Inc.
T D PattersonUniversity of California San Diego.
M NarasimhanUniversity of South Carolina.
P D HarveyUniversity of Miami Miller School of Medicine.
R S E KeefeNeuroCog Trials, Inc ; Duke University Medical Center.
University of California, San Diego · USUniversity of Miami · USUniversity of South Carolina · US

Funding

The Virtual Reality Functional Capacity Assessment Tool (VRFCAT) Validation StudyR44MH084240 · NIMH · VERASCI, LLC · PI ATKINS, ALEXANDRA STRICKLAND · 2012 to 2018
$3.4M
Computerized Interactive Assessment of Functional Skills for Schizophrenia Drug TR43MH084240 · NIMH · VERASCI, LLC · PI HURLEY, KOLLEEN, KEEFE, RICHARD S · 2009 to 2009
$137k
NIMH NIH HHS R43 MH084240NIMH NIH HHS R44 MH084240
6 · The paper itself

Abstract

Clinical trials for primary prevention and early intervention in preclinical AD require measures of functional capacity with improved sensitivity to deficits in healthier, non-demented individuals. To this end, the Virtual Reality Functional Capacity Assessment Tool (VRFCAT) was developed as a direct performance-based assessment of functional capacity that is sensitive to changes in function across multiple populations. Using a realistic virtual reality environment, the VRFCAT assesses a subject's ability to complete instrumental activities associated with a shopping trip. The present investigation represents an initial evaluation of the VRFCAT as a potential co-primary measure of functional capacity in healthy aging and preclinical MCI/AD by examining test-retest reliability and associations with cognitive performance in healthy young and older adults. The VRFCAT was compared and contrasted with the UPSA-2-VIM, a traditional performance-based assessment utilizing physical props. Results demonstrated strong age-related differences in performance on each VRFCAT outcome measure, including total completion time, total errors, and total forced progressions. VRFCAT performance showed strong correlations with cognitive performance across both age groups. VRFCAT Total Time demonstrated good test-retest reliability (ICC=.80 in young adults; ICC=.64 in older adults) and insignificant practice effects, indicating the measure is suitable for repeated testing in healthy populations. Taken together, these results provide preliminary support for the VRFCAT as a potential measure of functionally relevant change in primary prevention and preclinical AD/MCI trials.

Indexed as

agingFunctional capacityfunctional outcomemeaningful changeprodromal AD

Identifiers

PMID26618145
PMCPMC4657736
OpenAlexW2409946642

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.